CLASS II ONGOING Device recall · Reported 5 Feb 2025 · FDA Enforcement Report

Monitoring System recalled by Murata Vios

Murata Vios is recalling muRata Vios Monitoring System, distributed nationwide in the US. The recall was initiated on 22 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoft ware version 1.57.20, UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y
Quantity recalled62 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1069-2025
FDA event ID
96169
Recalling firm
Murata Vios, Woodbury, MN
Classification
Class II
Status
Ongoing
Recall initiated
22 Apr 2024
FDA classified
30 Jan 2025
Reported
5 Feb 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

22 Apr 2024Recall initiated by company
30 Jan 2025Classified by FDA+283 days
5 Feb 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate

Where it was distributed

Worldwide - US Nationwide distribution in the states of NY, TX, OH, MD and the country of India.

Nationwide MarylandNew YorkOhioTexas

Questions about this recall

Is Monitoring System recalled?

Yes. Murata Vios recalled Monitoring System on 22 Apr 2024. The recall is Class II and its status is Ongoing. Recall number Z-1069-2025.

Why was it recalled?

During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.

Which lots are affected?

Soft ware version 1.57.20, UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y

Where was it sold?

Worldwide - US Nationwide distribution in the states of NY, TX, OH, MD and the country of India.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Murata Vios

All 4

Other Patient Monitors recalls

All 1,013